# Transcranial Magnetic Stimulation and Pharmacologic/Probiotic Interventions for Diarrhea-Predominant IBS

> **NCT07172139** · NA · NOT_YET_RECRUITING · sponsor: **Rui Li** · enrollment: 140 (estimated)

## Conditions studied

- IBS (Irritable Bowel Syndrome)

## Interventions

- **COMBINATION_PRODUCT:** Active rTMS + Pinaverium Bromide
- **COMBINATION_PRODUCT:** Active rTMS + Bifidobacterium
- **COMBINATION_PRODUCT:** Sham Comparator: Sham rTMS + Pinaverium Bromide
- **COMBINATION_PRODUCT:** Placebo Comparator: Sham rTMS + Bifidobacterium

## Key facts

- **NCT ID:** NCT07172139
- **Lead sponsor:** Rui Li
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-09
- **Primary completion:** 2026-04
- **Final completion:** 2026-05
- **Target enrollment:** 140 (ESTIMATED)
- **Last updated:** 2025-09-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07172139

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07172139, "Transcranial Magnetic Stimulation and Pharmacologic/Probiotic Interventions for Diarrhea-Predominant IBS". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT07172139. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*